Amber Tarantini, APRN
Family · Oklahoma City, OKNPI 1306484803
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,177 of the $1,352 with a category attached, or 87.1%. It is spread thinly across 20 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $729, more than ten times the $44 reported in 2021.
Across 40 payments — averaging $33.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$246
- Astellas Pharma US Inc$230
- AstraZeneca$218
- Daiichi Sankyo Inc.$138
- AVEO Pharmaceuticals, Inc.$84
- Bayer$57
- plus $380 from 14 others
What the payments were for
- Food & beverage$1,17787%
- Education$17513%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 7 | $246 |
| Astellas Pharma US Inc | 4 | $230 |
| AstraZeneca | 5 | $218 |
| Daiichi Sankyo Inc. | 2 | $138 |
| AVEO Pharmaceuticals, Inc. | 3 | $84 |
| Bayer | 2 | $57 |
| Merck | 2 | $53 |
| Progenics Pharmaceuticals, Inc. | 2 | $48 |
| Urogen Pharma, Inc. | 2 | $42 |
| Genentech, Inc. | 1 | $35 |
| Incyte Corporation | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Tolmar, Inc. | 1 | $23 |
| Telix Pharmaceuticals | 1 | $18 |
| Tersera Therapeutics LLC | 1 | $17 |
| Amgen | 1 | $16 |
| Immunitybio, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,352 in reported general payments places this provider in the 75th percentile of 2,026 family providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 21 | $341 |
| Hydrocortisone | 13 | $239 |
| Gabapentin | 12 | $183 |
| Pantoprazole Sodium | 26 | $151 |
| Levothyroxine Sodium | 14 | $88 |
| Triamcinolone Acetonide | 11 | $86 |
| Prednisone | 15 | $53 |
Paid to pharmacies, not to this prescriber.
Other family in Oklahoma City
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Lacey HillOklahoma City$20K
- Julia John SamuelOklahoma City$17K
- Kristina SnyderOklahoma City$15K
- Lindi CiglarOklahoma City$15K
- Shymol JohnOklahoma City$14K
- Xiomara PorrasOklahoma City$12K
- Anne DudeOklahoma City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.